Activ-2 is all we need to talk about.28 Apr 2021 14:41
Funded by the US taxpayer for SNG's trial.
First dosing 12th Feb - with 14 and 28 day end points (and more of course).
FDA monitoring data as it comes in. FDA has power to stop trial at any point if the drug has safety or efficacy issues. On this basis we have endpoint data starting from 26th Feb and we are 61 days after that. I'd say we can safely say say things are ok because we know how touchy the public gets about wasted tax payer spending.